Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Catalyst-free synthesis method eliminates metal residues and simplifies scale-up, enhancing supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN115215779B enables efficient synthesis of chiral spirocyclic catalysts with simplified routes and high yield for reliable fine chemical supply chains.
Innovative benzofuran-based phosphine ligand enables high-yield Suzuki-Miyaura coupling with simplified synthesis, reducing manufacturing costs and improving supply chain reliability for fine chemicals.
Patent CN116813544A enables catalyst-free synthesis of high-purity quinoline intermediates, reducing manufacturing costs and lead times for pharmaceutical supply chains through green chemistry principles.
Novel chiral quaternary ammonium salt catalyst enables asymmetric alkylation with superior stereoselectivity while reducing lead time and production costs for pharmaceutical intermediates.
Catalyst-free synthesis of aryl acetonitrile derivatives enables high-purity API intermediates with simplified scale-up and reduced supply chain risks.
Patent CN109053556A enables high-purity fine chemical synthesis with mild conditions, reducing lead time and manufacturing costs for complex catalyst ligands.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.
Discover how ruthenium-catalyzed 3+2 cycloaddition enables efficient, single-step pyrrole synthesis with 50-71% yields, reducing multi-step costs and supply chain risks for pharmaceutical intermediates.
Discover catalyst-free oxadiazaborole synthesis with 5-min reaction time and >80% yield. Ideal for pharmaceutical intermediates with simplified purification and scalable production.
Discover a catalyst-free, high-yield method for chromone quinoline heterocycles. Reduce production costs and supply chain risks with this scalable process for pharmaceutical intermediates.
Discover a scalable, cost-effective synthesis method for indolocyclopentane compounds with >95% yield and 93% ee. Ideal for pharmaceutical R&D and production of prostate cancer therapeutics.
Solve supply chain risks with a novel quinazoline synthesis method. Achieve 99%+ purity and 90%+ yield without noble metals. Ideal for API production.
Solve enantioselectivity challenges in asymmetric hydrogenation with tunable bisphosphine ligands. Achieve 92-99% ee, recyclable catalysts, and simplified synthesis for cost-effective API production.
Solve low enantioselectivity in alpha-hydroxy-beta-keto ester synthesis. Our CDMO expertise scales this patent-protected catalyst for 87% ee, reducing R&D costs and supply chain risks. Contact for custom synthesis.
Discover catalyst-free, ethanol-based synthesis of 3,4-dihydro-3-(2-hydroxybenzoyl)-2(1H)-quinolinone with 70-80% yield. Reduce costs and supply chain risks for API manufacturing.
Solve quinazolinone synthesis challenges with non-toxic, high-yield one-step method. Reduce costs and supply chain risks for your drug development.
Discover N-N axis chiral indole-pyrrole synthesis with 97% ee, reducing R&D costs and supply chain risks for asymmetric pharmaceutical catalysts.
Discover a scalable, high-ee synthesis method for N-N axis chiral indole-pyrrole compounds. Ideal for chiral catalyst development with 97% ee and 62% yield. Reduce R&D costs and supply chain risks.
Discover how chiral phase transfer catalysis enables 92% ee and 80% yield in axial chiral isopyrone-indole synthesis for potent PC-3 tumor activity. Scale-ready for pharma R&D.